Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.6300
-0.0050-0.79%
Post-market: 0.63900.0090+1.43%19:56 EDT
Volume:449.80K
Turnover:300.53K
Market Cap:2.21M
PE:-0.02
High:0.7321
Open:0.6410
Low:0.6290
Close:0.6350
52wk High:60.00
52wk Low:0.6253
Shares:3.50M
Float Shares:1.25M
Volume Ratio:1.17
T/O Rate:35.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-32.4560
EPS(LYR):-371.2241
ROE:-126.98%
ROA:-62.31%
PB:0.22
PE(LYR):0.00

Loading ...

Apr 08, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 02, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 31, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 30, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report